Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-01-12

Clinical Trial Update: Role of CXCR2 Ligands/CXCR2 Biological Axis in Pancreatic Cancer

View source ↗

Summary

A Mayo Clinic–sponsored clinical trial investigated the role of CXCR2 ligands and the CXCR2 signaling axis in pancreatic cancer, including chronic pancreatitis …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Mayo Clinic | Conditions: Chronic Pancreatitis, Pancreatic Cancer | Status: COMPLETED